BBP

BioShares Biotechnology Products Fund
CLOSING PRICECHANGE (%)VOLUME
$41.24-- (--)1.17K
4:00:00 p.m. (ET) 07/26/2017
PRE-MARKET SESSION
LAST TRADECHANGE (%)
---- (--)
BID SIZEBID ($)ASK ($)ASK SIZE
--------
N/A

N/A
  • Overview
  • Efficiency
  • Tradability
  • Fit

BBP Fund Description

The BioShares Biotechnology Products ETF tracks an index of biotechnology companies considered to be in the "product stage" by the index provider.

BBP FactSet Analytics Insight

BBP offers a new and different approach to biotech investing by handpicking only firms that have attained FDA approval for their leading drug. The fund is offered by BioShares, a new issuer in the ETF landscape. (BioShares also launched a sister fund, BBC, which targets biotech firms in the “clinical trial stage.”) BBP is likely to tilt smaller than our neutral cap-weighted benchmark because the fund equal-weights its holdings. It charges a hefty 85 bps, which is the highest expense ratio in the segment. Even though BBP’s shown impressive trading volume in its early days, trade the fund with care to minimize potentially wide spreads often associated with newly launched ETFs. BBP is certainly a unique take on the biotech industry, and its remains to be seen how it will perform relative to a neutral cap-weighted benchmark.

BBP MSCI ESG Fund metrics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of July 25, 2017 the BioShares Biotechnology Products Fund MSCI ESG Fund Quality Score is 4.24 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. BBP ranks in the 19th percentile within its peer group and in the 14th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

BBP Top 10 Countries

BBP Top 10 Sectors

BBP Top 10 Holdings View All

BBP Summary Data

12/17/14
Open-Ended Fund
0.85%
$41.54 M
$302.89 K
0.31%

BBP Portfolio Data

$16.9 B
-26.97
6.68
0%
N/A
36

BBP Index Data

LifeSci Biotechnology Products Index
Equal
Proprietary
Thomson Reuters US Biotechnology & Medical Research

Related ETFs to BBP

XBI, FBT, CNCR, BBC
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

BBP Portfolio Management

0.85%
--
--
--

BBP Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

BBP Fund Structure

Open-Ended Fund
No
Yes
0% / 100%
N/A
N/A
Medium
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
------
------
------
------
------
------
------
------
------
------
Bats BZX Real-time Quote - 08:37:19
Daily Spread
Premium/Discount
Volume

BBP FactSet Analytics Block Liquidity

As of 07/26/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of BBP. BBP is rated a 4 out of 5.

BBP Tradability

7,728
$302.89 K
5,862
$232.09 K
0.31%
$0.12
0.03%
0.69% / -1.11%
None
100.00%
50,000
0.12
0.02%
0.41%
--
$41.28
4

BBP Performance Statistics

0.81
1.21
1.21
1.08
0.71%
Thomson Reuters US Biotechnology & Medical Research

BBP MSCI ESG Fund Metrics

4.24 / 10
18.63
13.80
--
20.95%
27.96